Product
Winlevi
Aliases
Winlevi (clascoterone) 1% & Adapalene 0.3% gel, Winlevi (clascoterone) 1% cream, Winlevi (clascoterone) 1% & Duac gel
Name
Winlevi
INN Name
Clascoterone
FDA Approved
Yes
6 clinical trials
1 organization
1 indication
1 document
Indication
Acne VulgarisClinical trial
The Combination Use of Winlevi and Adapalene 0.3% Gel in Real Life Acne TreatmentStatus: Active (not recruiting), Estimated PCD: 2024-09-01
Clinical trial
Combination Treatment of Winlevi With Duac Gel in Patients With Acne VulgarisStatus: Active (not recruiting), Estimated PCD: 2024-10-01
Clinical trial
Clinical Evaluation of the Sebum Reduction Induced by Clascoterone Cream 1%Status: Active (not recruiting), Estimated PCD: 2025-02-01
Clinical trial
A Clinical Study to Assess the Barrier Impact of WinleviStatus: Completed, Estimated PCD: 2023-12-16
Clinical trial
The Efficacy and Safety of Winlevi in Skin of Color Patients With AcneStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Clinical trial
Histologic and LCMS Evaluation of the Sebaceous Gland Changes Induced by Clascoterone Cream 1%Status: Not yet recruiting, Estimated PCD: 2024-09-01
Document
DailyMed Label: WinleviOrganization
Sun Pharmaceutical Industries, Inc.